[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$inbx](/topic/$inbx) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $IDYA Darovasertib + crizotinib $JAZZ Zanidatamab $INBX Ozekibart (INBRX-109) Access our FREE Big Mover Report" [X Link](https://x.com/BiopharmIQ/status/1979988861259583880) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-19T19:11Z 27.5K followers, 2207 engagements "Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $ATAI Phase 2b $INBX Phase X $SVRA Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $VOR Phase X $JAGX Phase X $ALXO Phase X $PROK Phase X $VRCA Phase X $KZR Phase 2a $IFRX Phase 2a $IFRX Phase 2b $ELDN Phase X $OSTX Phase 2b $NKTR Phase 2b $RZLT Phase X $PVLA Phase X $ARGX Phase X $INCY Phase X $WVE Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $ANRO Phase X $PRAX Phase 2/3 $BHVN Phase X $COGT Phase X $ALKS Phase X $MRUS Phase X $MRUS Phase X $MRUS Phase 2" [X Link](https://x.com/BiopharmIQ/status/1979988843597291585) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-19T19:11Z 27.5K followers, 19.5K engagements "🧬 Biopharma Weekly Recap 📝 This week in biotech: Gene therapy and CRISPR roar back as $QURE M&A chatter heats up $NTLA leads in vivo race institutional money piles into GLP-1 giants and $XBIs rally signals sector revival. See interesting posts/ppl to check out 👇 @ericjackson 💊 Rate Cuts. Risk On. Biotech Reawakens. $SANA Looks Like the Next 100-Bagger Platform. @yaireinhorn BioTech & Pharma rebound: $XBI +9.5% since Sept XX +16.6% YTD. Recovery looks real but IPOs will be the true test. @mikeaxolotl Thesis: $QURE will be acquired for $8.5-11.4B+ within 6-18 months. That's 138-200%+ upside" [X Link](https://x.com/BiopharmIQ/status/1979539567184347239) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-18T13:26Z 27.5K followers, 18K engagements "Healthy Chart Watch List (2025/10/17) $ATAI $MNMD $INBX $ASMB 10Day 21Day 50Day 50Day 150Day 200Day RS Line New High RS Rating XX A/D Rating AB Ind Group RS AB Comp Rating XX 50-Day Avg Vol (1000s) XXX Relative Strength Short-Term Strength XX% ADR% X ATR% Multiple From 50MA 05" [X Link](https://x.com/oratnek_ill/status/1979372542273163486) [@oratnek_ill](/creator/x/oratnek_ill) 2025-10-18T02:22Z 3567 followers, 1712 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% $IDYA Darovasertib + crizotinib $JAZZ Zanidatamab $INBX Ozekibart (INBRX-109) Access our FREE Big Mover Report"
X Link @BiopharmIQ 2025-10-19T19:11Z 27.5K followers, 2207 engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/3). $LQDA Phase X $ATAI Phase 2b $INBX Phase X $SVRA Phase X $IDYA Phase X $IDYA Phase 2/3 $KYTX Phase X $VOR Phase X $JAGX Phase X $ALXO Phase X $PROK Phase X $VRCA Phase X $KZR Phase 2a $IFRX Phase 2a $IFRX Phase 2b $ELDN Phase X $OSTX Phase 2b $NKTR Phase 2b $RZLT Phase X $PVLA Phase X $ARGX Phase X $INCY Phase X $WVE Phase X $EWTX Phase X $RNAC Phase X $ROIV Phase X $GLPG Phase X $MGNX Phase X $BHVN Phase X $ANRO Phase X $PRAX Phase 2/3 $BHVN Phase X $COGT Phase X $ALKS Phase X $MRUS Phase X $MRUS Phase X $MRUS Phase 2"
X Link @BiopharmIQ 2025-10-19T19:11Z 27.5K followers, 19.5K engagements
"🧬 Biopharma Weekly Recap 📝 This week in biotech: Gene therapy and CRISPR roar back as $QURE M&A chatter heats up $NTLA leads in vivo race institutional money piles into GLP-1 giants and $XBIs rally signals sector revival. See interesting posts/ppl to check out 👇 @ericjackson 💊 Rate Cuts. Risk On. Biotech Reawakens. $SANA Looks Like the Next 100-Bagger Platform. @yaireinhorn BioTech & Pharma rebound: $XBI +9.5% since Sept XX +16.6% YTD. Recovery looks real but IPOs will be the true test. @mikeaxolotl Thesis: $QURE will be acquired for $8.5-11.4B+ within 6-18 months. That's 138-200%+ upside"
X Link @BiopharmIQ 2025-10-18T13:26Z 27.5K followers, 18K engagements
"Healthy Chart Watch List (2025/10/17) $ATAI $MNMD $INBX $ASMB 10Day 21Day 50Day 50Day 150Day 200Day RS Line New High RS Rating XX A/D Rating AB Ind Group RS AB Comp Rating XX 50-Day Avg Vol (1000s) XXX Relative Strength Short-Term Strength XX% ADR% X ATR% Multiple From 50MA 05"
X Link @oratnek_ill 2025-10-18T02:22Z 3567 followers, 1712 engagements
/topic/$inbx/posts